Phase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma

K. L. Moek, W. M. Fiedler, J. C. von Einem, H. M. Verheul, T. Seufferlein, D. J. de Groot, V. Heinemann, M. Kebenko, C. W. Menke-van der Houven van Oordt, T. J. Ettrich, E. Rasmussen, P. Bogner, B. Sable, S. Stienen, E. G.E. de Vries

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)viii139-viii140
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - 1 Oct 2018

Cite this